[{"address1": "259 Liberty Avenue", "city": "Staten Island", "state": "NY", "zip": "10305", "country": "United States", "phone": "917 533 1469", "website": "https://www.acurxpharma.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Robert J. DeLuccia", "age": 78, "title": "Co-Founder & Executive Chairman", "yearBorn": 1946, "fiscalYear": 2024, "totalPay": 818930, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 6.5, "open": 6.35, "dayLow": 6.35, "dayHigh": 6.8, "regularMarketPreviousClose": 6.5, "regularMarketOpen": 6.35, "regularMarketDayLow": 6.35, "regularMarketDayHigh": 6.8, "payoutRatio": 0.0, "beta": -1.292, "forwardPE": -4.2000003, "volume": 80364, "regularMarketVolume": 78001, "averageVolume": 574339, "averageVolume10days": 128070, "averageDailyVolume10Day": 128070, "bid": 0.0, "ask": 0.0, "bidSize": 0, "askSize": 0, "marketCap": 13549413, "fiftyTwoWeekLow": 3.8, "fiftyTwoWeekHigh": 39.2, "allTimeHigh": 176.4, "allTimeLow": 3.8, "fiftyDayAverage": 5.11246, "twoHundredDayAverage": 8.67949, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 4252757, "profitMargins": 0.0, "floatShares": 1301227, "sharesOutstanding": 2081323, "sharesShort": 116032, "sharesShortPriorMonth": 25822, "sharesShortPreviousMonthDate": 1757894400, "dateShortInterest": 1760486400, "sharesPercentSharesOut": 0.0557, "heldPercentInsiders": 0.081149995, "heldPercentInstitutions": 0.13807, "shortRatio": 0.08, "shortPercentOfFloat": 0.0561, "impliedSharesOutstanding": 2081323, "bookValue": 2.425, "priceToBook": 2.6845362, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -9998860, "trailingEps": -10.57, "forwardEps": -1.55, "lastSplitFactor": "1:20", "lastSplitDate": 1754352000, "52WeekChange": -0.82777774, "SandP52WeekChange": 0.16625166, "quoteType": "EQUITY", "currentPrice": 6.51, "targetHighPrice": 165.8, "targetLowPrice": 20.0, "targetMeanPrice": 61.7, "targetMedianPrice": 30.5, "recommendationKey": "none", "numberOfAnalystOpinions": 4, "totalCash": 6064128, "totalCashPerShare": 3.826, "totalDebt": 0, "quickRatio": 2.355, "currentRatio": 2.376, "returnOnAssets": -0.98585, "returnOnEquity": -2.85935, "freeCashflow": -4532716, "operatingCashflow": -8162290, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "ACXP", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "regularMarketChangePercent": 0.15385, "regularMarketPrice": 6.51, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1624627800000, "postMarketChangePercent": -1.99693, "postMarketPrice": 6.38, "postMarketChange": -0.13, "regularMarketChange": 0.0100002, "regularMarketDayRange": "6.35 - 6.8", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 574339, "fiftyTwoWeekLowChange": 2.7100003, "fiftyTwoWeekLowChangePercent": 0.71315795, "fiftyTwoWeekRange": "3.8 - 39.2", "fiftyTwoWeekHighChange": -32.690002, "fiftyTwoWeekHighChangePercent": -0.83392864, "fiftyTwoWeekChangePercent": -82.77777, "earningsTimestamp": 1754971200, "earningsTimestampStart": 1763037000, "earningsTimestampEnd": 1763037000, "earningsCallTimestampStart": 1755000000, "earningsCallTimestampEnd": 1755000000, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -10.57, "epsForward": -1.55, "epsCurrentYear": -6.545, "corporateActions": [], "postMarketTime": 1761348556, "regularMarketTime": 1761336001, "exchange": "NCM", "messageBoardId": "finmb_558025934", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "shortName": "Acurx Pharmaceuticals, Inc.", "longName": "Acurx Pharmaceuticals, Inc.", "priceEpsCurrentYear": -0.99465245, "fiftyDayAverageChange": 1.3975401, "fiftyDayAverageChangePercent": 0.2733596, "twoHundredDayAverageChange": -2.1694899, "twoHundredDayAverageChangePercent": -0.24995591, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-06-25", "cryptoTradeable": false, "displayName": "Acurx Pharmaceuticals", "trailingPegRatio": null, "__fetch_time": "2025-10-25"}]